You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TP53 mutation

Showing 26 - 50 of 4,024
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult Trial in Saint Louis (Decitabine, Bone marrow biopsy/aspirate,

Terminated
Has Results
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Saint Louis, Missouri
    Washington University School of Medicine
May 9, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

DLBCL, Sintilimab, TP53 Mutation Trial (Sintilimab-R-CHOP)

Unknown status
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • (no location specified)
Dec 9, 2019

Prevention of Chemo-induced Myelosuppression Trial in Worldwide (ALRN-6924, TAC (doxorubicin 50 mg/m2; cyclophosphamide 500

Recruiting
  • Prevention of Chemotherapy-induced Myelosuppression
  • ALRN-6924
  • TAC (doxorubicin 50 mg/m2; cyclophosphamide 500 mg/m2; docetaxel 75 mg/m2)
  • Tamarac, Florida
  • +14 more
Jan 31, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia Trial (Nemtabrutinib, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Leukemia
  • (no location specified)
Nov 30, 2022

Non Small Cell Lung Cancer Trial in Italy (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Ancona, Italy
  • +10 more
Mar 14, 2023

Endometrial Cancer Trial (Navtemadlin, Navtemadlin Placebo)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Mar 21, 2023

Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

Not yet recruiting
  • Tumors
  • +4 more
  • Houston, Texas
    MD Anderson Cancer Center
Jun 20, 2022

MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

Terminated
  • MDS
  • Myelodysplastic Syndromes
  • APR-548 + Azacitidine
  • Tampa, Florida
  • +3 more
Jul 20, 2022

Myeloid Malignancy Trial in United States (APR-246, Venetoclax, Azacitidine)

Completed
  • Myeloid Malignancy
  • New Haven, Connecticut
  • +7 more
Jan 18, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Louisville, Kentucky
  • +66 more
Nov 9, 2022

Colorectal Cancer Trial in Salt Lake City (Cetuximab)

Recruiting
  • Colorectal Cancer
  • Salt Lake City, Utah
  • +1 more
May 3, 2022

Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

Not yet recruiting
  • Endometrial Cancer
  • (no location specified)
Aug 4, 2022

AML, Adult Trial in Berne (HDM201, Midostaurin)

Terminated
  • AML, Adult
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Oct 3, 2022

Biomarker Monitoring in TP53 Mutation Carriers

Completed
  • Li-Fraumeni Syndrome
  • +2 more
    • La Jolla, California
      Scripps Clinic Medical Group
    Sep 17, 2019

    Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Decitabine and

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Decitabine and Cedazuridine
    • +2 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    May 25, 2022

    p53 and Response to Preoperative Radiotherapy for T2 and T3

    Recruiting
    • Rectal Cancer
    • preoperative short course radiation
    • Vienna, Austria
      Medical University of Vienna, Department of Surgery
    Apr 6, 2022

    Acute Myeloid Leukemia Trial in Columbus (Decitabine, Nivolumab, Venetoclax)

    Suspended
    • Acute Myeloid Leukemia
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 5, 2022

    DLBCL Trial (Sintilimab, Rituximab)

    Not yet recruiting
    • Diffuse Large B-Cell Lymphoma
    • (no location specified)
    Mar 6, 2022

    Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome

    Completed
    • Li-Fraumeni Syndrome
    • Whole body MRI
    • Psychological questionnaires
    • Sutton, Surrey, United Kingdom
      Cancer Genetics Unit, Royal Marsden Hospital
    Mar 30, 2022

    P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

    Recruiting
    • P53 Mutation
    • +3 more
    • Shanghai, Shanghai, China
      Hematological department, Shanghai Institute of Hematology, Ruij
    Apr 20, 2021

    Solid Tumor Trial in United States (ASTX295)

    Recruiting
    • Solid Tumor
    • Duarte, California
    • +9 more
    Nov 18, 2022

    CLL/SLL Trial in Wuhan, Changsha (Orelabrutinib and BG)

    Not yet recruiting
    • CLL/SLL
    • Orelabrutinib and BG
    • Wuhan, Hubei, China
    • +1 more
    Jun 15, 2023

    Mantle Cell Lymphoma Recurrent Trial in Melbourne (ibrutinib and Tisagenlecleucel)

    Active, not recruiting
    • Mantle Cell Lymphoma Recurrent
    • ibrutinib and Tisagenlecleucel
    • Melbourne, Victoria, Australia
      Peter Mac Callum Cancer Centre
    Nov 4, 2022